Tags

Type your tag names separated by a space and hit enter

The production of pharmaceutical proteins from the milk of transgenic animals.
Reprod Nutr Dev. 1995; 35(6):609-17.RN

Abstract

The preparation of recombinant proteins of pharmaceutical interest from the milk of transgenic animals is becoming a reality. No protein has reached the market yet but several have been prepared in large quantities not only from laboratory animals but also from ruminants (goat and sheep) and pigs. Rabbit appears more and more to be an intermediate animal well adapted for the preparation of limited amounts of proteins. Several problems remain to be solved to optimize the method. The expression level of genes of interest associated with milk protein gene control regions is usually unpredictable. The recombinant proteins secreted in milk are not always in a satisfactory biochemical form. Cleavage and glycosylation are not always carried out correctly. The problem of the possible presence of agents pathogenic for humans in proteins extracted from milk is not completely solved. Prions have not been found in mammary glands and other milk pathogens may be controlled using good practice in breeding.

Authors+Show Affiliations

INRA, unité de différenciation cellulaire, Jouy-en-Josas, France.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

8534355

Citation

Houdebine, L M.. "The Production of Pharmaceutical Proteins From the Milk of Transgenic Animals." Reproduction, Nutrition, Development, vol. 35, no. 6, 1995, pp. 609-17.
Houdebine LM. The production of pharmaceutical proteins from the milk of transgenic animals. Reprod Nutr Dev. 1995;35(6):609-17.
Houdebine, L. M. (1995). The production of pharmaceutical proteins from the milk of transgenic animals. Reproduction, Nutrition, Development, 35(6), 609-17.
Houdebine LM. The Production of Pharmaceutical Proteins From the Milk of Transgenic Animals. Reprod Nutr Dev. 1995;35(6):609-17. PubMed PMID: 8534355.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The production of pharmaceutical proteins from the milk of transgenic animals. A1 - Houdebine,L M, PY - 1995/1/1/pubmed PY - 1995/1/1/medline PY - 1995/1/1/entrez SP - 609 EP - 17 JF - Reproduction, nutrition, development JO - Reprod. Nutr. Dev. VL - 35 IS - 6 N2 - The preparation of recombinant proteins of pharmaceutical interest from the milk of transgenic animals is becoming a reality. No protein has reached the market yet but several have been prepared in large quantities not only from laboratory animals but also from ruminants (goat and sheep) and pigs. Rabbit appears more and more to be an intermediate animal well adapted for the preparation of limited amounts of proteins. Several problems remain to be solved to optimize the method. The expression level of genes of interest associated with milk protein gene control regions is usually unpredictable. The recombinant proteins secreted in milk are not always in a satisfactory biochemical form. Cleavage and glycosylation are not always carried out correctly. The problem of the possible presence of agents pathogenic for humans in proteins extracted from milk is not completely solved. Prions have not been found in mammary glands and other milk pathogens may be controlled using good practice in breeding. SN - 0926-5287 UR - https://www.unboundmedicine.com/medline/citation/8534355/The_production_of_pharmaceutical_proteins_from_the_milk_of_transgenic_animals_ L2 - http://publications.edpsciences.org/10.1051/rnd:19950601 DB - PRIME DP - Unbound Medicine ER -